Inactief instrument
Sector Charles River Laboratories International, Inc. Xetra
Aandelen
RV6
US1598641074
Biotechnologie & Medisch Onderzoek
|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 204,95 EUR | -5,05% |
|
-10,60% | - |
| 29/07 | Align Technology breidt bestuur uit en start evaluatie na akkoord met Elliott | RE |
| 13/07 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : BofA Securities geeft koopadvies | ZM |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,86% | +4,93% | +2,20% | +19,99% | +6,92% | +0,52% | +13,82% | -19,51% | +217,33% | 49,37 mld. | |
| -3,95% | +14,70% | +23,07% | +50,15% | +5,49% | +24,15% | +5,15% | -4,00% | +206,27% | 39,14 mld. | |
| +6,22% | +1,81% | +2,61% | +33,34% | +141,27% | +419,17% | +647,45% | +570,98% | - | 40,85 mld. | |
| -1,57% | -1,44% | +13,02% | +9,08% | +6,01% | +7,38% | +43,06% | +1,73% | +1.127,44% | 35,81 mld. | |
| +5,56% | +11,70% | +6,03% | -2,21% | +10,22% | +11,64% | +51,50% | -11,63% | +159,73% | 30,5 mld. | |
| -0,39% | -0,63% | -5,87% | +9,46% | - | - | - | - | - | 16,55 mld. | |
| -1,13% | -4,54% | +9,20% | +38,13% | +2,96% | +32,10% | +126,95% | +228,69% | - | 16,14 mld. | |
| -7,10% | -2,81% | -4,71% | +39,89% | -9,16% | -8,80% | -34,35% | -31,96% | +113,12% | 12,77 mld. | |
| -0,26% | +3,04% | -0,06% | +18,25% | +9,65% | +1,63% | +9,33% | -32,47% | +101,92% | 13,71 mld. | |
| 0,00% | +0,36% | +1,95% | +30,21% | +22,48% | +24,81% | -14,04% | -40,25% | +156,29% | 11,22 mld. | |
| +4,61% | +0,62% | -3,40% | +13,39% | -5,73% | +77,34% | +547,83% | +288,03% | +2.583,22% | 10,77 mld. | |
| +0,07% | +0,03% | +1,18% | +62,02% | +77,93% | +257,09% | +547,23% | - | - | 10,08 mld. | |
| -3,25% | -7,67% | +24,47% | +22,86% | +26,66% | +11,90% | +37,29% | -59,07% | - | 8,9 mld. | |
| -1,41% | -4,64% | -32,80% | -28,73% | -32,65% | +22,85% | +33,90% | +43,46% | +82,53% | 8,85 mld. | |
| +1,67% | -3,05% | -6,68% | +32,00% | +37,53% | +142,82% | +389,97% | +77,82% | - | 8,8 mld. | |
| -0,86% | 0,00% | +6,01% | +19,87% | -12,44% | -22,13% | -21,19% | -29,65% | +33,43% | 8,57 mld. | |
| +4,24% | +2,37% | +13,10% | +40,08% | +58,74% | +153,83% | +626,24% | +180,48% | - | 8,92 mld. | |
| +5,75% | -4,54% | -8,08% | -3,48% | +4,41% | +443,82% | +1.993,54% | +31,52% | - | 8,58 mld. | |
| +3,50% | -5,55% | -4,51% | +48,41% | +78,81% | +79,13% | +73,96% | +93,39% | +0,26% | 8,39 mld. | |
| Gemiddelde | +0,66% | +1,54% | +1,93% | +23,83% | +23,84% | +93,29% | +282,09% | +75,74% | +434,69% | 18,31 mld. | |
| Gewogen gemiddelde per kap. | +0,77% | +4,48% | +4,84% | +23,98% | +28,03% | +90,73% | +213,15% | +94,48% | +425,45% |
Kies jouw editie
Alle financiële informatie op nationaal niveau
